TGFB1 and cancer: Immunosuppression by TGF‐β in cancer involves a phenotypic change in a variety of immune cells: dendritic cells, tumor‐associated macrophages (TAMS), tumor‐associated neutrophils, natural killer (NK) cells, myeloid‐derived suppressor cells (MDSCs), regulatory T cells (Treg cells), and cytotoxic T cells (Fig. 1) [8, 9, 23, 24].